Copyright
©The Author(s) 2024.
World J Gastroenterol. Dec 28, 2024; 30(48): 5174-5190
Published online Dec 28, 2024. doi: 10.3748/wjg.v30.i48.5174
Published online Dec 28, 2024. doi: 10.3748/wjg.v30.i48.5174
Figure 8 The mechanism by which the m6A-modified long noncoding RNA KIF9-AS1 promotes stemness and sorafenib resistance in hepatocellular carcinoma through ubiquitin-specific peptidase 1-mediated deubiquitination of short stature homeobox 2.
HCC: Hepatocellular carcinoma; USP1: Ubiquitin-specific peptidase 1; SHOX2: Short-stature homeobox 2; METTL3: Methyltransferase-like 3; IGF2BP1: Insulin-like growth factor 2 mRNA binding protein 1; m6A: N6-methyladenosine; Ub: Ubiquitin.
- Citation: Yu Y, Lu XH, Mu JS, Meng JY, Sun JS, Chen HX, Yan Y, Meng K. N6-methyladenosine-modified long non-coding RNA KIF9-AS1 promotes stemness and sorafenib resistance in hepatocellular carcinoma by upregulating SHOX2 expression. World J Gastroenterol 2024; 30(48): 5174-5190
- URL: https://www.wjgnet.com/1007-9327/full/v30/i48/5174.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i48.5174